Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMM-101 with SBRT in Metastatic Colorectal Cancer
NCT01539824Phase 2Completed
- Sponsor
- Immodulon Therapeutics
- Start
- May 2012
- Primary completion
- Mar 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of IMM-101 in colorectal cancer (metastatic) (mCRC), sponsored by Immodulon Therapeutics. Started May 2012; status: completed.
02
Drugs
IMM-101
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT01539824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01539824.